These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16019537)

  • 1. Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab.
    Robak E; Biernat W; Krykowski E; Jeziorski A; Robak T
    Leuk Lymphoma; 2005 Jun; 46(6):909-14. PubMed ID: 16019537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment.
    Papageorgiou KI; Kaniorou-Larai MG
    BMC Cancer; 2005 Aug; 5():106. PubMed ID: 16111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
    Robak P; Linke A; Cebula B; Robak T; Smolewski P
    Leuk Lymphoma; 2006 Dec; 47(12):2625-34. PubMed ID: 17169808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinoma.
    Craig PJ; Calonje JE; Harries M; Stefanato CM
    J Cutan Pathol; 2009 Jun; 36(6):706-10. PubMed ID: 19519600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
    Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ
    Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia.
    Robak E; Robak T; Biernat W; Bartkowiak J; Krykowski E
    Br J Dermatol; 2002 Oct; 147(4):775-80. PubMed ID: 12366429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
    Papalas JA; McKinney MS; Kulbacki E; Dave SS; Wang E
    Am J Dermatopathol; 2014 Feb; 36(2):148-52. PubMed ID: 24556900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collision tumor of primary merkel cell carcinoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, diagnosed on ultrasound-guided fine-needle aspiration biopsy: a unique case report and review of literature.
    Li Z; Yang JJ; Wu M
    Diagn Cytopathol; 2015 Jan; 43(1):66-71. PubMed ID: 24610800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cladribine in the treatment of chronic lymphocytic leukemia.
    Robak T
    Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
    Bertazzoni P; Rabascio C; Gigli F; Calabrese L; Radice D; Calleri A; Gregato G; Negri M; Liptrott SJ; Bassi S; Nassi L; Sammassimo S; Laszlo D; Preda L; Pruneri G; Orlando L; Martinelli G
    Leuk Lymphoma; 2010 Aug; 51(8):1485-93. PubMed ID: 20578816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
    Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
    J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
    Robak T; Smolewski P; Urbanska-Rys H; Gora-Tybor J; Blonski JZ; Kasznicki M
    Leuk Lymphoma; 2004 May; 45(5):937-44. PubMed ID: 15291352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy.
    Srock S; Schriever F; Neubauer A; Herold M; Huhn D
    Leuk Lymphoma; 2007 May; 48(5):905-11. PubMed ID: 17487734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.
    Robak T; Urbańska-Ryś H; Strzelecka B; Krykowski E; Bartkowiak J; Bĺoński JZ; Kordek R; Warzocha K
    Eur J Haematol; 2001; 67(5-6):322-7. PubMed ID: 11872081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Merkel cell carcinoma in a patient with chronic lymphocytic leukemia].
    Cervigón I; Gargallo AB; Bahillo C; Martínez-Amo JL; Orradre JL; Muñoz-Madero V; García-Almagro D
    Actas Dermosifiliogr; 2006 May; 97(4):264-6. PubMed ID: 16801021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab dose-escalation trial in chronic lymphocytic leukemia.
    O'Brien SM; Kantarjian H; Thomas DA; Giles FJ; Freireich EJ; Cortes J; Lerner S; Keating MJ
    J Clin Oncol; 2001 Apr; 19(8):2165-70. PubMed ID: 11304768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.